Search for: "GENENTECH, INC." Results 421 - 440 of 469
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Nov 2017, 9:04 am by Jason Rantanen
Eric Sutton is a senior patent counsel at Oracle and an adjunct professor at Chicago-Kent College of Law. [read post]
7 May 2010, 11:11 am
See Genentech, Inc. v. [read post]
3 Mar 2011, 5:52 pm
Cir. 1987), cert. denied, 484 U.S. 1025 (1988) (when facts are undisputed and issue is solely one of law, appellate court need not remand but may resolve issue); Genentech, Inc. v. [read post]
15 Dec 2014, 7:25 am
After his earlier post on Hospira v Genentech [on which see also the IPKat earlier note here], Darren provides a catch-up summarizing the large number of comments and the debate that it has generated. [read post]
14 Jan 2011, 4:19 am
 These companies include Genentech, Caterpillar Inc, Morphy Richards Ltd,  Styron Europe and Baker Tilly. [read post]
16 May 2012, 10:07 pm by Linda Moss
That $100 million study was the topic of a Page One story in The New York Times Wednesday, as well as coverage in papers such as The Wall Street Journal. http://www.nytimes.com/2012/05/16/health/research/prevention-is-goal-of-alzheimers-drug-trial.html http://online.wsj.com/article/SB10001424052702303505504577406431528720826.html That test will involve a drug from Genentech Inc., crenezumab, and most of the participants will “come from the world’s largest family to… [read post]
23 Mar 2011, 1:30 pm by Lucas A. Ferrara, Esq.
The drug is jointly developed by Genentech Inc., a member of the Roche group, under an agreement with Novartis Pharma AG. [read post]
6 Jan 2009, 9:14 am
Genentech case (opinion by Judge Newman) held that it would, while Atlantic Thermoplastics Co., Inc. v. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
9 Jan 2007, 11:56 pm
Genentech, written by Justice Antonin Scalia, overturns Federal Circuit doctrine in holding that patent licensees no longer have to breach the license in order to have standing to challenge the patent that they dispute. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
27 Sep 2009, 2:30 pm
As we noted in Genentech, Inc. v. [read post]
14 Apr 2010, 10:57 am
Although the PTO emphasizes that it was required to give all "claims their broadest reasonable construction" particularly with respect to claim 4's use of the open-ended term "comprising," see Genentech, Inc. v. [read post]